Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07507955 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Probiotics for Constipation Relief in Adults

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment increased: 70 → 105 participants
    • Start date: Apr 15, 2026 to Jun 10, 2026
    • Trial arms changed: 2 → 3
    • Interventions: Maltodextrin (Dietary Supplement), Probiotic (Dietary Supplement) to High-activity probiotic group (Dietary Supplement), Maltodextrin (Dietary Supplement), Probiotic (Dietary Supplement)
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the efficacy and safety of Bifidobacterium animalis subsp. lactis BLa36 in adults with functional constipation. In this randomized, double-blind, placebo-controlled trial, participants will receive BLa36 supplementation or placebo for 8 weeks. Clinical outcomes will be assessed using validated gastrointestinal symptom scales, stool characteristics, and quality-of-life measures. In addition, changes in inflammatory and immune markers, gut microbiota composition, metabolic indicators, and gut-brain axis-related parameters will be evaluated to comprehensively determine the effects of BLa36 on intestinal function and overall health.
Trial Details
NCT Number NCT07507955
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions
(from sponsor)		 Functional Constipation
Enrollment 105 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov